Adjutec Pharma AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2019, the company reported revenue of NOK 0 in its latest annual filing.
Forskning, utvikling, markedsføring og salg av nye hjelpestoffer (adjuvanter) som motvirker antibiotikaresistens, slik at kjente antibiotika virker bedre.
In its most recent annual report (2025), Adjutec Pharma AS reported revenue of NOK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of NOK 1.1m.
At the end of 2025, equity financed 71.1% of the balance sheet, and current assets covered short-term debt 11.9 times.
Frequently asked questions
What is the Org number of Adjutec Pharma AS?
Adjutec Pharma AS is registered with Brønnøysundsregistrene under Org 923831762.
Who is the CEO of Adjutec Pharma AS?
Jethro Lee Holter is the CEO of Adjutec Pharma AS, in role since 2025.
Who is the chairman of Adjutec Pharma AS?
Øyvind Kongstun Arnesen chairs the board of Adjutec Pharma AS, in role since 2024.
Where is Adjutec Pharma AS headquartered?
Adjutec Pharma AS's registered address is Ullernchausséen 64.
